India has essentially created a protectionist regime that harms US job creators."Despite being a member of the WTO and an important global trading partner, India has systematically failed to interpret and apply its IP laws in a manner consistent with recognised global standards," he said, adding that the Global IP Centre's International IP Index ranked India last in terms of overall IP protection.
Stating that in September last year, India revoked Pfizer's patent for a cancer medication, SUTENT, Waldron said this will now allow Indian generic companies to manufacture and sell generic copies of SUTENT long before the patent is set to expire.
Why not? It is very simple solution for a poor country like India. And I think that this approach will be popular in the future for other communist not-so-rich countries who will try to take care about the health of people.
No comments:
Post a Comment